Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global HM Market Portraiture
2.2. Global HM Market, by Product, 2017 (US$ Mn)
2.3. Global HM Market, by Application, 2017 (US$ Mn)
2.4. Global HM Market, by Geography, 2017 (US$ Mn)
Chapter 3. Human Microbiome (HM) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global HM Market, by Key Players, 2017
Chapter 4. Global Human Microbiome (HM) Market, by Product
4.1. Overview
4.2. Probiotics
4.3. Prebiotics
4.4. Medical Foods
4.5. Supplements
4.6. Others
Chapter 5. Global Human Microbiome (HM) Market, by Application
5.1. Overview
5.2. Diagnostics
5.3. Therapeutics
Chapter 6. Global Human Microbiome (HM) Market, by Geography
6.1. Overview
6.2. North America HM Market Analysis, 2016 – 2026
6.2.1. North America HM Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America HM Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America HM Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe HM Market Analysis, 2016 – 2026
6.3.1. Europe HM Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe HM Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific HM Market Analysis, 2016 – 2026
6.4.1. Asia Pacific HM Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific HM Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America HM Market Analysis, 2016 – 2026
6.5.1. Latin America HM Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America HM Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa HM Market Analysis, 2016 – 2026
6.6.1. MEA HM Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA HM Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. DuPont
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Enterome Bioscience
7.3. Osel, Inc.
7.4. Second Genome, Inc.
7.5. Seres Therapeutics
7.6. Synthetic Biologics, Inc.
7.7. Synlogic, Inc.
7.8. Vedanta Biosciences, Inc.
7.9. Vithera Pharmaceuticals
7.10. Yakult Honsha Co., Ltd.
List of Figures
FIG. 1 Human Microbiome (HM) Market: Research Methodology
FIG. 2 HM Market Segmentation
FIG. 3 Global HM Market, by Product, 2017 (US$ Mn)
FIG. 4 Global HM Market, by Applications, 2017 (US$ Mn)
FIG. 5 Global HM Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global HM Market, by Key Players, 2017
FIG. 8 Global Probiotics Market for Human Microbiome, 2016 – 2026 (US$ Mn)
FIG. 9 Global Prebiotics Market for Human Microbiome, 2016 – 2026 (US$ Mn)
FIG. 10 Global Medical Foods Market for Human Microbiome, 2016 – 2026 (US$ Mn)
FIG. 11 Global Supplements Market for Human Microbiome, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Products Market for Human Microbiome, 2016 – 2026 (US$ Mn)
FIG. 13 Global Diagnostics Market for Human Microbiome, 2016 – 2026 (US$ Mn)
FIG. 14 Global Therapeutics Market for Human Microbiome, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. HM Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada HM Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. HM Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany HM Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe HM Market, 2016 – 2026 (US$ Mn)
FIG. 20 China HM Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan HM Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific HM Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil HM Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico HM Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America HM Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC HM Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA HM Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Human Microbiome (HM) Market Portraiture
TABLE 2 Global HM Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global HM Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global HM Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America HM Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America HM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America HM Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe HM Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe HM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific HM Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific HM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America HM Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America HM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa HM Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa HM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa HM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 DuPont: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Enterome Bioscience: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Osel, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Second Genome, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Seres Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Synthetic Biologics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Synlogic, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Vedanta Biosciences, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Vithera Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Yakult Honsha Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)